Authors
Loading...
Analysis shows systemic inflammation drives clonal hematopoiesis in TET2 mutations, suggesting targeted therapeutic strategies may improve patient outcomes.
Encabo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: